Understanding and Reducing Ceruloplasmin Overuse with a Decision Support Intervention for Liver Disease Evaluation

American Journal of Medicine

Volumn 129, Issue 1, 2016, Pages 115.e17-115.e22

  Tapper, Elliot B ^a   Sengupta, Neil ^a   Lai, Michelle ^a   Horowitz, Gary ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Alanine aminotransferase; Cirrhosis; Liver tests; Wilson disease

Indexed keywords

CERULOPLASMIN;

ACETAMINOPHENI NDUCED ACUTE LIVER INJURY; ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CERULOPLASMIN BLOOD LEVEL; DECISION SUPPORT SYSTEM; DRUG INDUCED DISEASE; FALSE POSITIVE RESULT; FOLLOW UP; GASTROENTEROLOGIST; GILBERT DISEASE; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HOSPITAL; HUMAN; INTERNIST; LIVER DISEASE; LIVER INJURY; MAJOR CLINICAL STUDY; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PANCREAS CANCER; PATIENT REFERRAL; PHYSICIAN ORDER ENTRY SYSTEM; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TOXIC HEPATITIS; TREATMENT INDICATION; WILSON DISEASE; CLINICAL DECISION SUPPORT SYSTEM; HEPATOLENTICULAR DEGENERATION; MIDDLE AGED; UNNECESSARY PROCEDURE;

ADULT; CERULOPLASMIN; DECISION SUPPORT SYSTEMS, CLINICAL; HEPATOLENTICULAR DEGENERATION; HUMANS; MEDICAL ORDER ENTRY SYSTEMS; MIDDLE AGED; PROSPECTIVE STUDIES; UNNECESSARY PROCEDURES;

EID: 84979849201     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2015.07.019     Document Type: Article

References (30)

1. 1 Smith, M., Saunders, R., Stuckhardt, L., McGinnis, J.M., Best Care at Lower Cost: The Path to Continuously Learning Health Care in America. 2013, National Academies Press, Washington, DC.
2. 2 Berwick, D.M., Hackbarth, A.D., Eliminating waste in US health care. JAMA 307:14 (2012), 1513–1516.
3. 3 National Academy of Sciences, Institute of Medicine, Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. 2001, National Academies Press, Washington, DC.
4. 4 Morgan, D.J., Wright, S.M., Dhruva, S., Update on medical overuse. JAMA Intern Med 175:1 (2015), 120–124.
5. 5 Lichtenstein, M.J., Pincus, T., How useful are combinations of blood tests in “rheumatic panels” in diagnosis of rheumatic diseases?. J Gen Intern Med 3:5 (1988), 435–442.
6. 6 Tapper, E.B., Rahni, D.O., Arnaout, R., Lai, M., The overuse of serum ceruloplasmin measurement. Am J Med 126:10 (2013), 926.e1–926.e5.
7. 7 Tapper, E.B., Patwardhan, V.R., Curry, M., Low yield and utilization of confirmatory testing in a cohort of patients with liver disease assessed for Alpha-1 antitrypsin deficiency. Dig Dis Sci 60:6 (2015), 1589–1594.
8. 8 Welch, H.G., Passow, H.J., Quantifying the benefits and harms of screening mammography. JAMA Intern Med 174:3 (2014), 448–454.
9. 9 Roberts, E.A., Schilsky, M.L., Diagnosis and treatment of Wilson disease: an update. Hepatology 47:6 (2008), 2089–2111.
10. 10 Clark, J.M., Brancati, F.L., Diehl, A.M., The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98:5 (2003), 960–967.
11. 11 Cauza, E., Maier-Dobersberger, T., Polli, C., Kaserer, K., Kramer, L., Ferenci, P., Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin. J Hepatol 27:2 (1997), 358–362.
12. 12 Bates, D.W., Kuperman, G.J., Rittenberg, E., et al. A randomized trial of a computer-based intervention to reduce utilization of redundant laboratory tests. Am J Med 106:2 (1999), 144–150.
13. 13 Bates, D.W., Kuperman, G.J., Wang, S., et al. Ten commandments for effective clinical decision support: making the practice of evidence-based medicine a reality. J Am Med Inform Assoc 10:6 (2003), 523–530.
14. 14 Hunt, D.L., Haynes, R.B., Hanna, S.E., Smith, K., Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review. JAMA 280:15 (1998), 1339–1346.
15. 15 Kaushal, R., Shojania, K.G., Bates, D.W., Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med 163:12 (2003), 1409–1416.
16. 16 Lobach, D.F., Hammond, W., Computerized decision support based on a clinical practice guideline improves compliance with care standards. Am J Med 102:1 (1997), 89–98.
17. 17 Tapper, E.B., Sengupta, N., Lai, M., Horowitz, G., A Decision Support Tool to Reduce Overtesting for Ceruloplasmin and Improve Adherence With Clinical Guidelines. JAMA Intern Med, 2015.
18. 18 Davidoff, F., Batalden, P., Stevens, D., Ogrinc, G., Mooney, S., Publication guidelines for quality improvement in health care: evolution of the SQUIRE project. Qual Saf Health Care 17:Suppl 1 (2008), i3–i9.
19. 19 van Wijk, M.A., van der Lei, J., Mosseveld, M., Bohnen, A.M., van Bemmel, J.H., Assessment of decision support for blood test ordering in primary care: a randomized trial. Ann Intern Med 134:4 (2001), 274–281.
20. 20 Bright, T.J., Wong, A., Dhurjati, R., et al. Effect of clinical decision-support systemsa systematic review. Ann Intern Med 157:1 (2012), 29–43.
21. 21 O'Connor, A.M., Bennett, C.L., Stacey, D., et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev(3), 2009, CD001431.
22. 22 Shmerling, R.H., Delbanco, T.L., How useful is the rheumatoid factor?: an analysis of sensitivity, specificity, and predictive value. Arch Intern Med 152:12 (1992), 2417–2420.
23. 23 Solomon, D.H., Kavanaugh, A.J., Schur, P.H., Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Care Res 47:4 (2002), 434–444.
24. 24 Rao, J.K., Weinberger, M., Oddone, E.Z., Allen, N.B., Landsman, P., Feussner, J.R., The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis: a literature review and meta-analysis. Ann Intern Med 123:12 (1995), 925–932.
25. 25 Mandl, L.A., Solomon, D.H., Smith, E.L., Lew, R.A., Katz, J.N., Shmerling, R.H., Using antineutrophil cytoplasmic antibody testing to diagnose vasculitis: can test-ordering guidelines improve diagnostic accuracy?. Arch Intern Med 162:13 (2002), 1509–1514.
26. 26 Schober, S.E., Sinks, T.H., Jones, R.L., et al. Blood mercury levels in US children and women of childbearing age, 1999-2000. JAMA 289:13 (2003), 1667–1674.
27. 27 Licurse, A., Kim, M.C., Dziura, J., et al. Renal ultrasonography in the evaluation of acute kidney injury: developing a risk stratification framework. Arch Intern Med 170:21 (2010), 1900–1907.
28. 28 May, T.A., Clancy, M., Critchfield, J., et al. Reducing unnecessary inpatient laboratory testing in a teaching hospital. Am J Clin Pathol 126:2 (2006), 200–206.
29. 29 Stuebing, E.A., Miner, T.J., Surgical vampires and rising health care expenditure: reducing the cost of daily phlebotomy. Arch Surg 146:5 (2011), 524–527.
30. 30 Ala, A., Borjigin, J., Rochwarger, A., Schilsky, M., Wilson disease in septuagenarian siblings: raising the bar for diagnosis. Hepatology 41:3 (2005), 668–670.